chlordiazepoxide hydrochloride (Revogenex)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namechlordiazepoxide hydrochloride (Revogenex)
Drug Alias Namechlordiazepoxide hydrochlorideRVX-108
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRevogenex Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRevogenex Inc
Active IndicationsN/A
Inactive IndicationsIrritable Bowel Syndrome

Other Information

ATC CodeN/A
Related LinksN/A